BIOMAT Database Logo BIOMAT Database Logo

Antineoplastic properties of arylsulfonylhdrazones of 3-formylpyridazine 2-oxide and 4-formylpyrimidine 3-oxide. 1978

J A May, and A C Sartorelli

The antineoplastic activity of several arylsulfonylhydrazones of 4-formylpyrimidine 3-oxide and of 3-formylpyridazine 2-oxide has been investigated. Derivatives of the latter heteroaromatic N-oxide showed excellent antineoplastic potency against the murine neoplasm Sarcoma 180 but were inactive against leukemia L1210. In contrast, derivatives of 4-formylpyrimidine 3-oxide were inactive against both of these transplanted tumors.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005260 Female Females
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

J A May, and A C Sartorelli
Antineoplastic and biochemical properties of arylsulfonylhydrazones of 2-formylpyridine N-oxide.
June 1976, Journal of medicinal chemistry,
J A May, and A C Sartorelli
[Preparation and properties of some derivatives of 2-, 3-, and 4-(2-hydroxy-3-amino-propoxy)-2',3'- and 4-azachalcones].
November 1993, Die Pharmazie,
J A May, and A C Sartorelli
Crystal Structure and Magnetic Properties of [Cu(4-Me-3-Nit-trz)(4)](ClO(4))(2), with 4-Me-3-Nit-trz = 2-(3-[4-Methyl-1,2,4-triazolyl])-4,4,5,5-tetramethylimidazoline-1-oxyl 3-Oxide. Intra- and Intermolecular Spin Interactions.
January 1996, Inorganic chemistry,
J A May, and A C Sartorelli
Synthesis, basicity, structural characterization, and biochemical properties of two [(3-hydroxy-4-pyron-2-yl)methyl]amine derivatives showing antineoplastic features.
March 2012, The Journal of organic chemistry,
J A May, and A C Sartorelli
[ANTINEOPLASTIC EFFECTS OF 7-MEMBERED RING COMPOUNDS. 3. ANTINEOPLASTIC EFFECTS OF 2-ISONICOTINOYL HYDRAZINO-5-NITROSOTROPONE-N-OXIDE (RCH-1003)].
May 1964, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
J A May, and A C Sartorelli
[Synthesis, properties, and biological activity of some substituted 2'-, 3-, 3'-, 4- and 4'-azachalcones].
November 1993, Die Pharmazie,
J A May, and A C Sartorelli
[Antiarrhythmic properties of 4-4 (4 'methoxyphenyl) (3' 'methyl 4' 'oxyphenyl) butylamine 2].
November 1955, Archives internationales de pharmacodynamie et de therapie,
J A May, and A C Sartorelli
2'-(Trimethylammonio)ethyl 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate: a novel potent antineoplastic agent.
January 1993, Journal of medicinal chemistry,
J A May, and A C Sartorelli
Syntheses, X-ray Structures, and Solution Properties of [V(4)O(4){(OCH(2))(3)CCH(3)}(3)(OC(2)H(5))(3)] and [V(4)O(4){(OCH(2))(3)CCH(3)}(2)(OCH(3))(6)]: Examples of New Ligand Coordination Modes.
March 1997, Inorganic chemistry,
J A May, and A C Sartorelli
Synthesis and coordination properties of 1-(diphenylphosphine oxide)-1-(2'-pyridyl N-oxide)-3-(diphenylphosphine oxide)propane.
January 2002, Inorganic chemistry,
Copied contents to your clipboard!